Northern Trust Corp Liquidia Corp Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in Liquidia Corp stock. As of the latest transaction made, Northern Trust Corp holds 493,540 shares of LQDA stock, worth $7.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
493,540
Previous 438,600
12.53%
Holding current value
$7.21 Million
Previous $5.26 Million
6.23%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding LQDA
# of Institutions
170Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$105 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$61.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$50.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$48 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$46.6 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $940M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...